Your browser doesn't support javascript.
loading
Timing of the infusion of nivolumab for patients with recurrent or metastatic squamous cell carcinoma of the esophagus influences its efficacy.
Nomura, Motoo; Hosokai, Taisuke; Tamaoki, Masashi; Yokoyama, Akira; Matsumoto, Shigemi; Muto, Manabu.
Affiliation
  • Nomura M; Department of Clinical Oncology, Kyoto University Hospital, 54 Kawahara-Cho, Shogoin, Sakyo-Ku, Kyoto, 606-8507, Japan. excell@hkg.odn.ne.jp.
  • Hosokai T; Department of Clinical Oncology, Kyoto University Hospital, 54 Kawahara-Cho, Shogoin, Sakyo-Ku, Kyoto, 606-8507, Japan.
  • Tamaoki M; Department of Clinical Oncology, Kyoto University Hospital, 54 Kawahara-Cho, Shogoin, Sakyo-Ku, Kyoto, 606-8507, Japan.
  • Yokoyama A; Department of Clinical Oncology, Kyoto University Hospital, 54 Kawahara-Cho, Shogoin, Sakyo-Ku, Kyoto, 606-8507, Japan.
  • Matsumoto S; Department of Clinical Oncology, Kyoto University Hospital, 54 Kawahara-Cho, Shogoin, Sakyo-Ku, Kyoto, 606-8507, Japan.
  • Muto M; Department of Clinical Oncology, Kyoto University Hospital, 54 Kawahara-Cho, Shogoin, Sakyo-Ku, Kyoto, 606-8507, Japan.
Esophagus ; 20(4): 722-731, 2023 10.
Article in En | MEDLINE | ID: mdl-37093536
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Esophageal Neoplasms / Carcinoma, Squamous Cell / Esophageal Squamous Cell Carcinoma Type of study: Observational_studies Limits: Humans Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Esophageal Neoplasms / Carcinoma, Squamous Cell / Esophageal Squamous Cell Carcinoma Type of study: Observational_studies Limits: Humans Language: En Year: 2023 Type: Article